News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
350 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (271)
2 (281)
3 (275)
4 (131)
5 (1)
6 (2)
7 (16)
8 (364)
9 (350)
10 (293)
11 (152)
12 (2)
13 (18)
14 (265)
15 (311)
16 (221)
17 (246)
18 (119)
19 (10)
20 (22)
21 (217)
22 (249)
23 (226)
24 (235)
25 (118)
26 (2)
27 (5)
28 (204)
29 (282)
30 (224)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
BioCapital
OncoImmune Raises $56 Million to Advance Anti-Inflammatory and Oncology Pipeline
Rockville, Maryland-based OncoImmune closed on a Series B round worth $56 million.
September 9, 2020
·
2 min read
·
Mark Terry
Drug Development
Feline Antiviral Therapy Shows Promise Against SARS-CoV-2 in Human Cells
A study published in Nature Communications on August 27 shows that a feline antiviral drug was effective at inhibiting the replication of human coronaviruses in cell cultures infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
September 9, 2020
·
2 min read
·
Brandon May
Job Trends
AstraZeneca Pauses Phase III COVID-19 Vaccine Trial Due to Patient Illness
AstraZeneca paused its Phase III COVID-19 vaccine trial following a report of an “unexplained illness” in a patient involved in the study.
September 9, 2020
·
3 min read
·
Alex Keown
Drug Development
Preclinical Data Supports Efficacy for Pfizer, BioNTech Phase II/III COVID-19 Vaccine
Preclinical data for Pfizer and BioNTech’s Phase II/III COVID-19 mRNA vaccine candidate generated BNT162b2 strong anti-viral effects against an infectious SARS-CoV-2 challenge.
September 9, 2020
·
3 min read
·
Alex Keown
Drug Development
Amryt Eyes Approval for Epidermolysis Bullosa Drug Filsuvez Following Phase III Data
This morning, Dublin-based Amryt said the primary endpoint of the late-stage study was met. Look at what else the phase III trial of Filsuvez depicted.
September 9, 2020
·
2 min read
·
Alex Keown
Business
An Overview of Citi’s 15th Annual BioPharma Conference 2020 Boston
Like almost all conferences this year, Citi’s 15th Annual BioPharma Conference 2020 is being held virtually.
September 9, 2020
·
4 min read
·
Mark Terry
Business
Can High Blood Sugar (hyperglycemia) Haunt People with Diabetes Even After it is Under Control?
In people with diabetes, periods of high blood sugar (hyperglycemia) can negatively impact their health years later, even if they get their blood sugar under control.
September 9, 2020
·
8 min read
·
Chelsea Weidman Burke
BioSpace Global Roundup, Sept. 10
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
September 9, 2020
·
8 min read
·
Alex Keown
BioCapital
HemoSonics Adds Remote Viewer to its Quantra® QPlus® System, Bringing Rapid Results to Clinicians Anywhere in the Hospital
HemoSonics announced today that its Quantra Desktop Remote Viewer Software (QDRV) has received a 510(k) clearance from the FDA. The QDRV enables remote access to its flagship product, the Quantra QPlus System.
September 9, 2020
·
3 min read
Business
New Outpatient Cath Lab Opens
Dr. Suresh Neelagaru is opening the Lonestar Cardiovascular Center to bring quality care, cost savings, and convenience to the area
September 9, 2020
·
2 min read
1 of 35
Next